18F-FDG uptake as a surrogate marker for antecedent ischemia

Journal of Nuclear Medicine

Volumn 49, Issue 12, 2008, Pages 1909-1911

  Dilsizian, Vasken ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; AMMONIA N 13; DOBUTAMINE; FATTY ACID; FLUORODEOXYGLUCOSE F 18; GLUCOSE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PALMITIC ACID C 11; RUBIDIUM 82; WATER O 15; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

CELL ENERGY; CELL VIABILITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MARKER; DRUG UPTAKE; ELECTROCARDIOGRAPHY; ENERGY METABOLISM; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GLUCOSE METABOLISM; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; LOW DRUG DOSE; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; THORAX PAIN; CORONARY ARTERY DISEASE; EXERCISE TEST; HUMAN; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; NOTE; SCINTISCANNING;

CORONARY ARTERY DISEASE; EXERCISE TEST; FLUORODEOXYGLUCOSE F18; HUMANS; METABOLIC CLEARANCE RATE; MYOCARDIAL ISCHEMIA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 50349084151     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.053892     Document Type: Review

References (19)

1. Tillisch JH, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314:884-888.
2. He ZX, Shi RF, Wu YJ, et al. Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease. Circulation. 2003;108:1208-1213.
3. 18F-FDG uptake after exercise-induced myocardial ischemia in patients with coronary artery disease. J Nucl Med. 2008;49:1986-1991.
4. Kawai Y, Tsukamoto E, Nozaki Y, Morita K, Sakurai M, Tamaki N. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol. 2001;38:1888-1894.
5. 123I]-iodophenylpentadecanoic acid identifies ischemic memory after demand ischemia. Circulation. 2005;112:2169-2174.
6. Goodwin GW, Taylor CS, Taegtmeyer H. Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem. 1998;273:29530-29539.
7. Taegtmeyer H, Dilsizian V. Imaging myocardial metabolism and ischemic memory. Nat Clin Pract Cardiovasc Med. 2008;5(suppl 2):S42-S48.
8. Sun KT, Czernin J, Krivokapich J, et al. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation. 1996;94:3146-3154.
9. Panza JA, Dilsizian V, Laurienzo JM, Curiel RV, Katsiyiannis PT. Relation between thallium uptake and contractile response to dobutamine: implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation. 1995;91:990-998.
10. McNulty PH, Jagasia D, Cline GW, et al. Persistent changes in myocardial glucose metabolism in vivo during reperfusion of a limited-duration coronary occlusion. Circulation. 2000;101:917-922.
11. 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. Circulation. 1986;74:81-88.
12. Schelbert HR, Henze E, Phelps ME, Kuhl DE. Assessment of regional myocardial ischemia by positron-emission computed tomography. Am Heart J. 1982;103:588-597.
13. Sun D, Nguyen N, DeGrado TR, Schwaiger M, Brosius FC III. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation. 1994;89:793-798.
14. Young LH, Renfu Y, Russell R, et al. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation. 1997;95:415-422.
15. Egert S, Nguyen N, Schwaiger M. Contribution of α-adrenergic and β-adrenergic stimulation to ischemia-induced glucose transporter (GLUT) 4 and GLUT1 translocation in the isolated perfused rat heart. Circ Res. 1999;84:1407-1415.
16. Marwick TH, Nemec JJ, Lafont A, Salcedo EE, MacIntyre WJ. Prediction by postexercise fluoro-18 deoxyglucose positron emission tomography of improvement in exercise capacity after revascularization. Am J Cardiol. 1992;69:854-859.
17. Araujo LI, McFalls EO, Lammertsma AA, Jones T, Maseri A. Dipyridamole-induced increased glucose uptake in patients with single-vessel coronary artery disease assessed with PET. J Nucl Cardiol. 2001;8:339-346.
18. Abramson BL, Ruddy TD, deKemp RA, Laramee LA, Marquis JF, Beanlands RS. Stress perfusion/metabolism imaging: a pilot study for a potential new approach to the diagnosis of coronary disease in women. J Nucl Cardiol. 2000;7:205-212.
19. Gropler RJ, Siegel BA, Lee KJ, et al. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med. 1990;31:1749-1756.